Anti-cancer drugs, GI, toxicology Flashcards
anticancer drugs kill a fixed proportion of tumor cell population
log-kill hypothesis
cell-cycle specific drugs: M phase
MVVP: vinblastine, vincristine, paclitaxel
cell-cycle specific drugs: S phase
CHEM 66: cytaribine, hydroxyurea, etoposide, mtx, 6-mercaptopurine, 6-thioguanine
cell-cycle specific drugs: G2 phase; SE
bleomycin; pulmonary fibrosis
rescue therapy: methotrexate
leucovorin
rescue therapy: cyclophosphamide
mesna
rescue therapy: doxorubicin
doxrazoxane
rescue therapy: cisplatin
amifostine (amy at faustine)
decrease nephrotoxicity of cisplatin by administering _____ with _____
mannitol; forced hydration
alkylating agent with disulfiram-like reaction, leukemogenic
procarbazine
alkylating agent which exhibits phototoxicity, not leukemogenic
dacarbazine
marrow-sparing alkylating agent
busulfan
highly lipophilic alkylating agent, can cross BBB and cause CNS toxicity, used for brain tumors
carmustine or lomustine
inhibits de novo purine nucleotide synthesis, activated by HGPRT, cell cycle specific; metabolism is inhibited by ___ and ____
6-mercaptopurine; allopurinol and febuxostat
cause thymine-less cell death; inhibits thymidylate synthase, cell cycle specific, causes alopecia
5-FU
inhibits ribonucleotide reductase, cell cycle specific
cytaribine, gemcitabine
prevents microtubule assembly, causing cell arrest at metaphase
vincristine and vinblastine
vinca alkaloid which causes myelosuppression
vinblastine
inhibits DNA topoisomerase II (gyrase), cell cycle specific
etoposide, teniposide
inhibits DNA topoisomerase I (swivelase)
topotecan (2nd line for ovarian CA, small cell lung CA), irinotecan (metastatic colorectal CA)
prevents microtubule disassembly
paclitaxel, docetaxel
inhibits DNA topoisomerase II (gyrase), cell cycle nonspecific, can cause reversible dilated CM
doxorubicin
anti-tumor antibiotic which inhibits DNA-dependent RNA synthesis, cell cycle nonspecific, used for melanoma, wilms, rhabdomyosarcoma, kaposi sarcoma, GTN
actinomycin D
tyrosine kinase inhibitors
imatinib, dasatinib, nilotinib
uses of imatinib
CML (via bcr-abl), GIST (via c-kit)
MAB used for metastatic breast CA via Her2neu receptor
trastuzumab
MAB inhibiting binding of BEGF, inhibits tumor vascular permeability
bevacizumab
MAB used for NHL
rituximab
chemotherapeutic drugs causing myelosuppression
MTX, 5-FU, 6-MP, vinblastine